AstraZeneca asks Supreme Court to hear lawsuit challenging Medicare drug price negotiation
AstraZeneca has asked the Supreme Court to hear its case challenging the Medicare Drug Price Negotiation Program created through the Inflation Reduction Act (IRA). According to the Supreme Court’s docket, AstraZeneca’s petition was filed on Sept. 19. The company has asked the court to consider “whether the IRA implicates an interest of pharmaceutical manufacturers that…
